Thank you, Matt, and good morning, everyone. As a reminder, our results for the quarter include P3 Technologies, which we acquired in November of 2023. I will begin on Slide 6. As you can see, we achieved another record quarter with sales totaling $53.6 million, a 19% increase over last year and was across all our diversified revenue base. This increase also included $0.9 million of incremental sales from P3. Sales to the defense market were a major driver, reaching $30.9 million, which represents a 23% increase over the prior year. This growth was fueled by the expansion of new defense programs, a ramp up in existing programs and a timing of critical project milestones. Additionally, higher refining and chemical petrochemical sales contributed $2.2 million to the overall growth, mainly reflecting the timing of capital improvement projects. Although our aftermarket sales were down compared to last year’s record levels, they remained strong, underscoring the resilience of our aftermarket business. U.S. sales made up 85% of our total revenue, highlighting the scale and importance of our domestic defense business. Turning to Slide 7, our gross margin expanded by 790 basis points to 23.9%. This improvement was driven by higher sales volume, a favorable project mix, enhanced pricing and strong operational execution. Our gross profit for the quarter also benefited $0.4 million or roughly 80 basis points from the BlueForge Alliance Grant. This $2.1 million grant, which we announced in July, supports our defense welder training program in Batavia and funds-related equipment. The grant will continue to contribute to our gross margin over the next two quarters at similar levels, aligning with our commitment to workforce development and securing skilled labor for future growth. As a reminder, the BlueForge Alliance is a non-profit that supports the U.S. Navy’s submarine industrial base and we are grateful for this partnership as we expand our capabilities and talent pipeline. On Slide 8, we see how our strong performance is boosting our bottomline. GAAP net income for the second quarter reached $3.3 million, a significant increase from the $0.4 million in the same period of fiscal 2024, translating to $0.30 per diluted share. This quarter’s results include $0.6 million -- a $0.6 million reversal of a previously accrued earn-out liability for P3. This adjustment was not due to any lost orders, but rather the timing of projects which extend beyond the earn-out period. Excluding this item, among others, our adjusted net income grew by 353% to $3.4 million or $0.31 per diluted share. While our effective tax rate can fluctuate quarterly based on factors like projected income levels, the mix of foreign-derived income and discrete items, this year’s tax rate reflects a benefit from the vesting of restricted stock awards in the first quarter, bringing our year-to-date effective tax rate to approximately 18% and was at a more normalized level in Q2 at 23.6%. For the full fiscal year, we continue to expect our effective tax rate to be between 20% and 22%. Slide 9 highlights our adjusted EBITDA, which totaled $5.6 million for the second quarter, reflecting a 10.5% margin, an expansion of 550 basis points over the prior year. While our SG&A expenses increased this quarter by $2.8 million over the prior year, this rise was primarily attributed to our strategic investments in operations, personnel and technology. Specifically, we incurred $0.4 million in additional costs related to the P3 acquisition, along with a $0.3 million increase in the supplemental performance bonus from the Barber-Nichols acquisition. We also recorded $0.2 million in expenses for the ERP conversion at our Batavia facility and another $0.2 million in increased investment in R&D. The remainder of the SG&A increase reflects costs associated with our overall growth, inflation and various ongoing initiatives. Overall, these investments position us well for future growth and support our long-term objectives. I should point out that the supplemental performance bonus from the Barber-Nichols acquisition was $1.1 million during the quarter, or approximately 200 basis points of revenue and will be completed at the end of fiscal 2026. Turning to Slide 10, we continue to demonstrate robust cash generation, reporting $13.9 million of cash flow from operations for the quarter. Our balance sheet remains strong, with $32.3 million in cash and no outstanding debt. Additionally, we have $43 million available on our revolving credit facility as of September 30th, providing us with significant financial flexibility to pursue our strategic growth initiatives. For the quarter, our capital expenditures totaled $3.5 million and are focused on capacity expansion and productivity enhancement, including investments in automated welding equipment and new machining centers. Additionally, approximately $1.5 million of this CapEx plan is related to the customer-supported expansion of our Batavia facility, which is essential for accommodating an accelerated shipbuilding schedule for the U.S. Navy. Given our recent land acquisition in Arvada, Colorado, and plans to construct a cryogenic testing facility in Florida that Matt discussed, we have increased our fiscal 2025 capital expenditure expectations to a range of $13 million to $18 million, up from the previous $10 million to $15 million. We expect this elevated level of capital spend of around 7% to 10% of sales to continue for the next several years in order to meet our long-term growth objectives. I should point out that nearly all of our large capital projects have a return on investment greater than 20% and that our maintenance CapEx is approximately $2 million. Turning to Slide 11, we reported orders of $63.7 million for the quarter, resulting in a book-to-bill ratio of 1.2 times. Notably, approximately half of these orders were for the defense sector, including the award for the MK19 Air Turbine Pump used in the torpedo ejection system of the Columbia-class submarine that we announced in August. In addition, we saw an increase in orders for the space sector, which totaled $13.5 million in the quarter. This included a key contract for a cryogenic recirculation pump for one of our large space customers. Furthermore, our refining orders totaled $10.6 million for the quarter, driven by ongoing strength in aftermarket orders. Aftermarket orders to the refining and chemical petrochemical market totaled $13 million for the quarter, up 11% over the prior year. Slide 12 highlights our backlog, which reached a record $407 million at September 30th, due to our consistent order demand and strong market position. This robust backlog not only provides us with excellent visibility into the future, but also ensures a high degree of operational stability. Overall, our backlog has grown by 30% year-over-year, with the defense backlog increasing by 31% or nearly $77 million. Our space backlog has surged by 150%, up almost $11 million, while our chemical and petrochemical backlog has risen by 58%, or approximately $8 million. It’s nice to see our backlog growing across all of mark -- all of our diversified markets. We expect approximately 35% to 45% of our backlog to convert to sales within the next 12 months, with an additional 30% to 40% projected for conversion over the following 12 months. It is important to note that the majority of the orders anticipated to convert beyond 12 months are from the defense sector, primarily for the U.S. Navy. On slide 13, we are updating our guidance for fiscal 2025 from what we provided last quarter. We continue to anticipate revenue between $200 million and $210 million, which reflects a projected topline growth of 11% over fiscal 2024, at the midpoint of this range. However, based upon the results to-date, our better-than-expected gross margins, and expectations for the remainder of the year, we are raising our adjusted EBITDA guidance by $1.5 million on the top and bottom end of the range to $18 million to $21 million, implying a 47% increase at the midpoint. This range also suggests an adjusted EBITDA margin of approximately 9.5% at the midpoint, representing a 230 basis point improvement over fiscal 2024. I should point out that we have taken into account the seasonal cadence in our projections, noting historically lighter third-quarter revenue due to the holidays and direct labor vacations. On Slide 14, we emphasize our strategic and operational priorities that are essential for achieving our long-term goals. We are making steady progress in meeting our targets and strategically positioning ourselves for sustained growth. This momentum, coupled with our recent adjustment to the EBITDA guidance, keeps us on track to achieve our goal of low-to-mid-teen adjusted EBITDA margins by fiscal 2027, just two short years away. Importantly, an additional component that will help bridge our progress toward this long-range goal is the completion of the Barber-Nichols Supplemental Bonus expense at the end of fiscal 2026. This will contribute approximately 200 basis points to our adjusted EBITDA margin in fiscal 2027. With that, we can now open the call for questions.